In type 1 diabetes, autoimmune T cells cause destruction of pancreatic ␤ cells by largely unknown mechanism. Previous analyses have shown that ␤ cell destruction is delayed but can occur in perforin-deficient nonobese diabetic (NOD) mice and that Fas-deficient NOD mice do not develop diabetes. However, because of possible pleiotropic functions of Fas, it was not clear whether the Fas receptor was an essential mediator of ␤ cell death in type 1 diabetes. To directly test this hypothesis, we have generated a ␤ cell-specific knockout of the Fas gene in a transgenic model of type 1 autoimmune diabetes in which CD4 ϩ T cells with a transgenic TCR specific for influenza hemagglutinin (HA) are causing diabetes in mice that express HA under control of the rat insulin promoter. Here we show that the Fas-deficient mice develop autoimmune diabetes with slightly accelerated kinetics indicating that Fas-dependent apoptosis of ␤ cells is a dispensable mode of cell death in this disease.
Introduction
Nonobese diabetic (NOD) mice are thought to represent a suitable animal model of human type 1 diabetes (1, 2) . In this model, the disease depends on the activation of autoimmune T cells by peptides presented by the particular NOD class II (g7) MHC allele that controls disease. In addition, several T cell receptor transgenic models of type 1 diabetes have been developed in which particularly high frequencies of CD4 or CD8 T cells specific for antigens expressed in ␤ cells cause pancreatic islet cell infiltration with subsequent destruction of ␤ cells (3, 4) . In the NOD and in some transgenic models (3, 5, 6) , the disease can be precipitated when CD4 T cells from diabetic mice are transferred into immunodeficient recipients where diabetes develops within 1-2 wk. Nevertheless, the mechanism of ␤ cell destruction has remained obscure. It became clear that perforin-deficient NOD mice exhibited a delayed onset of disease (7, 8) , but it was not obvious whether the late phase of ␤ cell destruction was affected. On the other hand, it was shown that Fasdeficient lpr/lpr mice on the NOD background did not develop diabetes (9) . Additional analyses had suggested that Fas was present on ␤ cells (9) and that expression increased during development of the disease. Other studies, however, also revealed that in Fas-deficient NOD mice there was no infiltration of pancreatic islets by mononuclear cells (10) , thus leaving open the question of whether Fas was directly involved in ␤ cell death. More recent studies using a dominant negative Fas mutation (11) or in vivo anti-Fas L antibody treatment (12) were interpreted to indicate that Fas may have a role in promoting predominantly early stages of the disease. To address a potential role of Fas in ␤ cell destruction conclusively, we have produced a conditional Fas allele (fas fl ) in which the death domain-encoding exon 9 is flanked by loxP sites, allowing for cell type-specific Fas inactivation (unpublished data). To analyze whether Fas inactivation in pancreatic ␤ cells resulted in resistance to the development of diabetes, the fas fl allele and a rat insulin promoter (RIP)-controlled Cre transgene (13) were introduced into a transgenic model of type 1 diabetes in which a transgenic TCR recognizes peptide 111-119 of influenza hemagglutinin (HA) expressed under control of the RIP and presented by class II 
Materials and Methods
Mice and Genotyping. TCR-HA mice and Ins-HA mice were bred as heterozygous transgenic mice and are on the BALB/c background. Fas fl mice derived from C57Bl/6 were created by homologous recombination using a conditional Fas allele in which the exon 9 has been flanked by loxP sites. RIP-Cre mice were on a mixed 129sv, C57Bl/6, and DBA-2 background (13). All animals were maintained in a pathogen-free facility in accordance with the guidelines of the Committee on Animals of Harvard Medical School. Genotyping of transgenes was determined by PCR on tail DNA. Primer sequences were 5 Ј -GGCTACCATGCGAACAAT-TCACCCG-3 Ј and 5 Ј -CTCCGTCAGCCATAGCAAATTT-CTG-3 Ј for the HA transgene, 5 Ј -ACAAGGTGGCAGTAA-CAGGA-3 Ј and 5 Ј -ACAGTCAGTCTGGTTCCTGA-3 Ј for the TCR-HA transgene, 5 Ј -CGATGCAACGAGTGATGAGG-3 Ј and 5 Ј -CATCGCTCGACCAGTTTAGT-3 Ј for the Cre transgene, and 5 Ј -TGCAGTTGCTGAGATGAACCATTTTCTCT-GTCT-3 Ј (P1) and 5 Ј -GGCTTTGGAAAGGAATTTCCTC-CTAAGAGG-3 Ј (P2) for WT and floxed Fas alleles. A 430-bp amplified product indicated the presence of a WT Fas allele, whereas a 470-bp amplified product indicated the presence of a floxed Fas allele, since the sense primer was located in exon 9 and the antisense one 3 Ј to the loxP site downstream of exon 9 ( Fig. 1  A) . Homozygosity for I-E d was determined by staining peripheral blood leukocytes.
RIP-Cre-mediated Fas Recombination in Islet DNA. DNA was prepared from the thymus, liver, heart, and islets isolated at the Harvard Medical School Islet Core Rodent Isolation. RIP-Cremediated Fas recombination was assessed using a sense primer with the sequence 5 Ј -GTCCTCTATTATCCTCATCATGAG-3 Ј (P3) located upstream of the 5 Ј loxP site and the antisense primer located downstream of the 3 Ј loxP site (P2). A 1.7-kb amplified product indicated the presence of intact exon 9, whereas a 260-bp amplified product indicated the presence of a deleted exon 9.
Diabetes Monitoring and Cyclophosphamide Administration. Development of spontaneous diabetes was assessed by measuring blood glucose twice a week with an automatic glucometer (Accu-chek Advantage; Roche). Cyclophosphamide (SigmaAldrich) in PBS was injected intraperitoneally at a dose of 200 mg/kg. Blood glucose levels of cyclophosphamide-treated mice were monitored daily.
Adoptive Transfer of Diabetes. CD4 ϩ TCR-HA-expressing cells were purified by sorting lymphocytes from spleen and LN of RAG-2 Ϫ / Ϫ , TCR-HA ϩ / Ϫ mice stained with the 6.5 (anti-TCR-HA) and anti-CD4 (GK1.5; BD Biosciences) mAbs. 10 5 sorted 6.5 ϩ CD4 ϩ cells were i.v. injected into either RAG-2 Ϫ / Ϫ , Fas fl/fl , Rip-cre ϩ / Ϫ , Ins-HA ϩ / Ϫ or RAG-2 Ϫ / Ϫ , Fas fl/fl , Rip-cre Ϫ / Ϫ , Ins-HA ϩ / Ϫ mice. Blood glucose levels of the recipients were tested daily.
Results and Discussion
The efficacy and tissue specificity of Cre-mediated deletion of Fas -exon 9 was assessed by PCR on DNA prepared from purified islets and various tissues from Cre-expressing and -nonexpressing Fas fl homozygous mice. Fig. 1 A depicts a schematic representation of mutated and WT Fas alleles and the position of the primers used to assess littermate genotype and ␤ cell-specific loss of functional Fas allele. Fig.  1 B shows that, regardless of Cre expression, DNA of nonpancreatic origin yielded a single 1.7-kb P2/P3 PCR product indicative of the sole presence of Fas -exon 9 (Fig. 1 A) . Even traces of recombined Fas -exon 9 would have been detected by the presence of a 260-bp fragment, which because of its short size would be favored over the 1.7-kb fragment. Evidence for islet-specific Cre-mediated deletion of exon 9 came from the single 260-bp P2/P3 PCR product that was obtained from islets of Cre-expressing mice, whereas a single 1.7-kb band was detected from the islets of Cre-nonexpressing mice. PCR analysis of the same samples using the P1/P2 primers that hybridize to WT nonrecombined but not to recombined Fas alleles (Fig. 1 A) yielded a single 470-bp band in nonpancreatic tissues of mice irrespective of RIP-Cre expression and in islets of mice lacking RIP-Cre (Fig. 1 B) . A much fainter 470-bp band was seen 
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in islets of Cre-expressing mice (Fig. 1 B) . This faint band is likely to reflect the fact that whole islets such as those used in the present study contain cells other than ␤ cells ‫,)%03ف(‬ e.g., non-␤ endocrine cells, macrophages, endothelial cells, etc., lacking Cre expression. Thus, the absence of amplification of a 260-bp P2/P3 PCR product (which will be favored over the 1.7-kb P2/P3 PCR product) in nonpancreatic tissues and its detection only in Cre-expressing islets and the diminution of the 470-bp fragment intensity in Creexpressing islets strongly suggest that the RIP-Cre-mediated recombination resulted in tissue-specific deletion of functional Fas in the vast majority of ␤ cells. Since the development of diabetes with blood sugar levels exceeding 200 mg/ dl requires destruction of well over 50% of all ␤ cells, the conditional knockout was suitable to reveal a possible essential role of Fas in the development of diabetes, since any Fas-dependent destruction of ␤ cells could not exceed 50% in these particular mice, and thus be insufficient to result in diabetes. Previous work using a RIP-Cre transgenic mouse line identical to that of the present study could not find evidence for a toxic effect of the transgene to the ␤ cells, their function, or the glucose tolerance of RIP-Cre transgenic mice (13, 14) . Furthermore, the Fas fl heterozygous, TCR-HA, Ins-HA, RIP-Cre transgenic breeders used in this study to generate the Fas-competent and -deficient TCR-HA, Ins-HA mice behaved identically to TCR-HA, Ins-HA double transgenic mice with respect to diabetes development, fertility, and frequency of the expected genotypes among their litter. Thus, we could exclude a role for the RIP-Cre transgene in potential phenotypical differences between RIP-Cre-expressing and -nonexpressing mice. To assess the impact of Fas expression by ␤ cells in their T cellmediated destruction, we compared the development of spontaneous autoimmune diabetes in the TCR-HA, Ins-HA transgenic model in which the floxed Fas alleles are recombined by the Cre recombinase (TCR-HA ϩ/Ϫ , Ins-HA ϩ/Ϫ , Fas fl/fl , RIP-Cre ϩ/Ϫ mice) to that of transgenic littermates lacking Cre expression (TCR-HA ϩ/Ϫ , Ins-HA ϩ/Ϫ , Fas fl/fl , RIP-Cre Ϫ/Ϫ mice) (Fig. 2) . The incidence and onset of diabetes in the latter quadruple transgenic littermates was not different from that in TCR-HA, Ins-HA double transgenic mice, indicating that neither the introduced floxed Fas alleles nor the mixed genetic background brought by the Fas floxed and RIP-Cre transgenic mice did perturb autoimmunity. The elimination of Fas by Cre recombinase did not produce a delay in the onset but some acceleration of the onset of diabetes (Fig. 2) . A similar conclusion, namely that Fas deficiency did not delay the onset of diabetes, was reached when diabetes was analyzed in TCR-HA, Ins-HA mice transgenic mice with a ␤ cell-specific deletion of Fas that were treated with 200 mg/kg cyclosphosphamide. This treatment is known to precipitate diabetes in NOD and TCR-HA, Ins-HA mice with similar kinetics, perhaps by interfering with regulatory (suppressive) T cells that control the development of disease. The RIP-Creexpressing mice came down with diabetes 4-5 d after treatment with the drug, indicating that also under these conditions Fas did not play a discernible role in ␤ cell death caused by autoimmune T cells (Fig. 3) . Finally, it was tested whether purified CD4 ϩ TCR-HA-expressing T cells from TCR-HA transgenic RAG-2 Ϫ/Ϫ mice could cause ␤ cell destruction in the absence of CD8 ϩ T cells by transferring them into Ins-HA transgenic mice on the RAG-2 Ϫ/Ϫ background lacking or expressing fas on ␤ cells. As shown in Fig.  4 , diabetes developed in both types of recipients within a short time period after injection of 10 5 CD4 ϩ T cells.
In both the NOD model (2) and in several TCR transgenic models (3, 5, 6) , the autoimmune disease can be transferred with purified CD4 T cells into immunodeficient mice that themselves do not have any T cells. Since only a few activated CD4 ϩ T cells express perforin but most express Fas ligand, it was conceivable that such T cells destroyed ␤ cells by a Fas L-Fas interaction that required direct cell contact. Our findings refute this hypothesis and are consistent with the notion that ␤ cells from Fas-deficient mice that were transplanted into Fas-competent mice are effectively destroyed by diabetogenic T cells (14-16) even though it is not clear in the latter scenario whether destruction of the transplanted ␤ cells occurs by the same mechanism as that of ␤ cells in situ. Our results are also consistent with the finding that a dominant negative Fas transgene in NOD mice had little effect on the development of diabetes when splenocytes from diabetic animals were transferred into x-irradiated transgenic nondiabetic recipients (11) .
By eliminating the Fas L-Fas apoptotic system as the essential mediator of ␤ cell death in type 1 diabetes, our results should shift the focus to other mediators of apoptotic cell death that do not require direct contact between T cells and ␤ cells. With regard to this notion, we may point out that there is apparently no significant expression of class II MHC on ␤ islet cells (1) and perhaps even more conclusively that antigen-specific contact between T cells and ␤ cells is not required for the T cell-mediated destruction of ␤ cells (17) . Thus, the search for mediators of ␤ cell destruction needs to focus on molecules that play an essential role in ␤ cell destruction in type 1 autoimmune diabetes and differ from Fas. The identification of such essential mediators of ␤ cell death would perhaps permit interference with the disease once the process of destruction has begun and first symptoms are detectable.
